Targeting ASIC1 in primary progressive multiple sclerosis: evidence of neuroprotection with amiloride

Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model

(2011) Sandra Vergo et al.   BRAIN

T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis

(2010) B. Bodini et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial

(2010) Raju Kapoor et al.   LANCET NEUROLOGY

Clinico-pathological evidence that axonal loss underlies disability in progressive multiple sclerosis

(2010) Emma C Tallantyre et al.   Multiple Sclerosis Journal

Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes

(2010) N. De Stefano et al.   NEUROLOGY

Thalamic Damage and Long-term Progression of Disability in Multiple Sclerosis

(2010) Maria Assunta Rocca et al.   RADIOLOGY

Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial

(2009) Kathleen Hawker et al.   ANNALS OF NEUROLOGY

A single-center, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis

(2009) X. Montalban et al.   Multiple Sclerosis Journal

Imaging outcomes for neuroprotection and repair in multiple sclerosis trials

(2009) Frederik Barkhof et al.   Nature Reviews Neurology

Mechanisms of Disease: sodium channels and neuroprotection in multiple sclerosis—current status

(2008) Stephen G Waxman   Nature clinical practice. Neurology

Corticospinal Tract Abnormalities Are Associated with Weakness in Multiple Sclerosis

(2007) D.S. Reich et al.   AMERICAN JOURNAL OF NEURORADIOLOGY